Cyanotech Promotes BioAstin Benefits

KAILUA-KONA, Hawaii Cyanotech announced its BioAstin® natural astaxanthin ingredient has undergone FDA review for a total of 17 structure/function claims, allowing companies marketing BioAstin to use the claims in their marketing. Finally, we can advertise the benefits of BioAstin to consumers in the United States, said Gerry Cysewski, CEO and founder of Cyanotech. The company noted the legality of using the claims in marketing varies in other countries. Cyanotech also holds three patents on the use of astaxanthin in human nutrition, and three patents related to the production of microalgae.